These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34363796)

  • 21. Lyn Kinase Suppresses the Transcriptional Activity of IRF5 in the TLR-MyD88 Pathway to Restrain the Development of Autoimmunity.
    Ban T; Sato GR; Nishiyama A; Akiyama A; Takasuna M; Umehara M; Suzuki S; Ichino M; Matsunaga S; Kimura A; Kimura Y; Yanai H; Miyashita S; Kuromitsu J; Tsukahara K; Yoshimatsu K; Endo I; Yamamoto T; Hirano H; Ryo A; Taniguchi T; Tamura T
    Immunity; 2016 Aug; 45(2):319-32. PubMed ID: 27521268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCG Increased Membrane Expression of TRIM59 Through the TLR2/ TLR4/IRF5 Pathway in RAW264.7 Macrophages.
    Jin Z; Tian Y; Yan D; Li D; Zhu X
    Protein Pept Lett; 2017; 24(8):765-770. PubMed ID: 28820065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbial recognition by GEF-H1 controls IKKε mediated activation of IRF5.
    Zhao Y; Zagani R; Park SM; Yoshida N; Shah P; Reinecker HC
    Nat Commun; 2019 Mar; 10(1):1349. PubMed ID: 30902986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microglial IRF5-IRF4 regulatory axis regulates neuroinflammation after cerebral ischemia and impacts stroke outcomes.
    Al Mamun A; Chauhan A; Qi S; Ngwa C; Xu Y; Sharmeen R; Hazen AL; Li J; Aronowski JA; McCullough LD; Liu F
    Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1742-1752. PubMed ID: 31892541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
    Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
    Front Immunol; 2018; 9():1297. PubMed ID: 29963044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis.
    Pandey AK; Yang Y; Jiang Z; Fortune SM; Coulombe F; Behr MA; Fitzgerald KA; Sassetti CM; Kelliher MA
    PLoS Pathog; 2009 Jul; 5(7):e1000500. PubMed ID: 19578435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2.
    Yasuda K; Watkins AA; Kochar GS; Wilson GE; Laskow B; Richez C; Bonegio RG; Rifkin IR
    PLoS One; 2014; 9(7):e103478. PubMed ID: 25076492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation and function of interferon regulatory factor 5.
    Ryzhakov G; Eames HL; Udalova IA
    J Interferon Cytokine Res; 2015 Feb; 35(2):71-8. PubMed ID: 25259415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. cGAS/STING/TBK1/IRF3 Signaling Pathway Activates BMDCs Maturation Following
    Li Q; Liu C; Yue R; El-Ashram S; Wang J; He X; Zhao D; Zhou X; Xu L
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses.
    Carlin AF; Plummer EM; Vizcarra EA; Sheets N; Joo Y; Tang W; Day J; Greenbaum J; Glass CK; Diamond MS; Shresta S
    Cell Rep; 2017 Nov; 21(6):1600-1612. PubMed ID: 29117564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma.
    Cevik O; Li D; Baljinnyam E; Manvar D; Pimenta EM; Waris G; Barnes BJ; Kaushik-Basu N
    J Biol Chem; 2017 Dec; 292(52):21676-21689. PubMed ID: 29079574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model.
    Duffau P; Menn-Josephy H; Cuda CM; Dominguez S; Aprahamian TR; Watkins AA; Yasuda K; Monach P; Lafyatis R; Rice LM; Kenneth Haines G; Gravallese EM; Baum R; Richez C; Perlman H; Bonegio RG; Rifkin IR
    Arthritis Rheumatol; 2015 Dec; 67(12):3146-57. PubMed ID: 26315890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2.
    Yasuda K; Nündel K; Watkins AA; Dhawan T; Bonegio RG; Ubellacker JM; Marshak-Rothstein A; Rifkin IR
    Int Immunol; 2013 May; 25(5):295-306. PubMed ID: 23291967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity.
    Kulkarni RR; Rasheed MA; Bhaumik SK; Ranjan P; Cao W; Davis C; Marisetti K; Thomas S; Gangappa S; Sambhara S; Murali-Krishna K
    J Virol; 2014 Dec; 88(24):13990-4001. PubMed ID: 25253340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus.
    Savitsky DA; Yanai H; Tamura T; Taniguchi T; Honda K
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10154-9. PubMed ID: 20479222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response.
    Fang CM; Roy S; Nielsen E; Paul M; Maul R; Paun A; Koentgen F; Raval FM; Szomolanyi-Tsuda E; Pitha PM
    Genes Immun; 2012 Jul; 13(5):421-30. PubMed ID: 22535200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
    Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
    Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.
    Bi X; Hameed M; Mirani N; Pimenta EM; Anari J; Barnes BJ
    Breast Cancer Res; 2011; 13(6):R111. PubMed ID: 22053985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An oligodeoxynucleotide with AAAG repeats significantly attenuates burn-induced systemic inflammatory responses via inhibiting interferon regulatory factor 5 pathway.
    Xiao Y; Lu W; Li X; Zhao P; Yao Y; Wang X; Wang Y; Lin Z; Yu Y; Hua S; Wang L
    Mol Med; 2017 Sep; 23():166-176. PubMed ID: 28620671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.